TY - JOUR
T1 - Heart valve critical pathway and heart valve clinic: novel benchmarks for modern management of valvular heart disease
AU - Pavone, Natalia
AU - Burzotta, Francesco
AU - Bruno, Piergiorgio
AU - Spalletta, Claudio
AU - Farina, Piero
AU - Cammertoni, Federico
AU - Nesta, Marialisa
AU - Chiariello, Giovanni A
AU - Grandinetti, Maria
AU - De Belvis, Antonio
AU - Marzetti, Emanuele
AU - Angioletti, Carmen
AU - Pasquini, Annalisa
AU - Mazza, Andrea
AU - Iafrancesco, Mauro
AU - Trani, Carlo
AU - Lombardo, Antonella
AU - Massetti, Massimo
PY - 2021
Y1 - 2021
N2 - The growing burden of valvular heart disease in Western countries represents a challenge for the daily clinical practice, especially in the light of the ever-increasing number of therapeutic options. The Euro Heart Survey showed that, among elderly subjects with severe, symptomatic valve dysfunction, surgery is denied for 33% of patients with aortic stenosis and for 50% of patients with mitral regurgitation. Current management (from diagnosis to follow-up) is often fragmented in multiple-sometimes unnecessary-steps. Such a "patchy" approach may translate into a suboptimal management, especially in the geriatric population. New healthcare models exist that can coordinate care, reduce fragmentation, limit costs and, ultimately, improve outcomes: the clinical pathways.
AB - The growing burden of valvular heart disease in Western countries represents a challenge for the daily clinical practice, especially in the light of the ever-increasing number of therapeutic options. The Euro Heart Survey showed that, among elderly subjects with severe, symptomatic valve dysfunction, surgery is denied for 33% of patients with aortic stenosis and for 50% of patients with mitral regurgitation. Current management (from diagnosis to follow-up) is often fragmented in multiple-sometimes unnecessary-steps. Such a "patchy" approach may translate into a suboptimal management, especially in the geriatric population. New healthcare models exist that can coordinate care, reduce fragmentation, limit costs and, ultimately, improve outcomes: the clinical pathways.
KW - Critical pathway
KW - Heart valve clinic
KW - Personalized medicine
KW - Valvular heart disease
KW - Critical pathway
KW - Heart valve clinic
KW - Personalized medicine
KW - Valvular heart disease
UR - https://publicatt.unicatt.it/handle/10807/181058
UR - https://www.scopus.com/inward/citedby.uri?partnerID=HzOxMe3b&scp=85113829365&origin=inward
UR - https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=85113829365&origin=inward
U2 - 10.1097/HPC.0000000000000260
DO - 10.1097/HPC.0000000000000260
M3 - Article
SN - 1535-282X
VL - 20
SP - 126
EP - 133
JO - Critical Pathways in Cardiology
JF - Critical Pathways in Cardiology
IS - 3
ER -